NCT00427349 2023-07-05AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsEastern Cooperative Oncology GroupPhase 2 Completed46 enrolled 7 charts
NCT00121628 2013-10-09A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid CancerAmgenPhase 2 Completed184 enrolled